Jundishapur Journal of Microbiology

Published by: Kowsar

Post-Vaccination Immunity Against Measles in Under Twenty-Five-Year-Old Population of Ahvaz, Southwest of Iran

Abdolhussein Shakurnia 1 , Seyed Mohammad Alavi 2 , Reza Norouzirad 3 , * , Amir Arsalan Sarajian 4 and Ghodratollah Shakerinejad 4
Authors Information
1 Depatment of Immunology, Health Research Institute, Infectious and Tropical Disease Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
2 Department of Infectious disease, Health Research Institute, Infectious and Tropical Disease Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
3 Department of Biochemistry, Dezful University of Medical Sciences, Dezful, IR Iran
4 Department of Health Research Center, Khuzetan Jahade Daneshgahi, Ahvaz, IR Iran
Article information
  • Jundishapur Journal of Microbiology: December 01, 2013, 6 (10); e7707
  • Published Online: December 1, 2013
  • Article Type: Research Article
  • Received: August 11, 2012
  • Revised: December 23, 2012
  • Accepted: January 16, 2013
  • DOI: 10.5812/jjm.7707

To Cite: Shakurnia A, Alavi S M, Norouzirad R, Sarajian A A, Shakerinejad G. Post-Vaccination Immunity Against Measles in Under Twenty-Five-Year-Old Population of Ahvaz, Southwest of Iran, Jundishapur J Microbiol. 2013 ; 6(10):e7707. doi: 10.5812/jjm.7707.

Abstract
Copyright © 2013, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Christie AS, Gay A. The Measles Initiative: moving toward measles eradication. J Infect Dis. 2011; 204 Suppl 1-7[DOI][PubMed]
  • 2. Hall R, Jolley D. International measles incidence and immunization coverage. J Infect Dis. 2011; 204 Suppl 1-63[DOI][PubMed]
  • 3. Kaninda AV, Legros D, Jataou IM, Malfait P, Maisonneuve M, et al. . Meales vaccine effectiveness in standard early immunization strategies, Niger, 1995. Pediatr Infect Dis J. 1998; 17: 1034-39
  • 4. Gaafar T, Moshni E, Lievano F. The challenge of achieving measles elimination in the Eastern Mediterranean Region by 2010. J Infect Dis. 2003; 187-71
  • 5. Mokhtari Azad T, Mahmoodi M, Hamkar R, et al. . [Epidemiologic feature of measles in Iran, 1995-96]. Hakim Res J. 2000; 1: 19-26
  • 6. Griffine DE. Fields Virology. 2001; : 1401-41
  • 7. Muller CP. Measles elimination: old and new challenges? Vaccine. 2001; 19(17-19): 2258-61[PubMed]
  • 8. Bataweel NA, Al-Robasi AA, Hasoon S, Al-Jabri AA, Sallam TA. Effect of first and second doses of Measles vaccine on immunity to measles among infants in sana’a city, Yaman. J Arab Board Health Special. 2012; 13(1): 10-15
  • 9. Naouri B, Ahmed H, Bekhit R, Teleb N, Mohsni E, Alexander JP, Jr. Progress toward measles elimination in the Eastern Mediterranean Region. J Infect Dis. 2011; 204 Suppl 1-98[DOI][PubMed]
  • 10. Khalil MK, Al-Mazrou YY, AlHowasi MN, Al-Jeffri M. Measles in Saudi Arabia: from control to elimination. Ann Saudi Med. 2005; 25(4): 324-8[PubMed]
  • 11. Zahraei SeyedMohsen, Gouya MohamadM, Azad TalatMokhtari, Soltanshahi Rambod, Sabouri Azam, Naouri Boubker, et al. Successful control and impending elimination of measles in the Islamic Republic of Iran. J Infect Dis. 2011; 204-11
  • 12. Zahraei SM, Sadrizadeh B, Gouya MM. Eradication of poliomyelitis in Iran, a historical perspective. Iran J Public Health. 2009; 38
  • 13. Majdzadeh R, Moradi A, Zeraati H, Sepanlou SG, Zamani G, Zonobi V. Evaluation of the measles-rubella mass vaccination campaign in the population covered by Tehran University of Medical Sciences. East Mediterr Health J. 2008; 14(4): 810-7[PubMed]
  • 14. Morgan OliverWC. Following in the footsteps of smallpox: can we achieve the global eradication of measles? BMC Int Health Hum Rights. 2004; 4(1): 1-5[DOI]
  • 15. Peltola Heikki, Jokinen Sari, Paunio Mikko, Hovi Tapani, Davidkin Irja. Measles, mumps, and rubella in Finland: 25 years of a nationwide elimination programme. The Lancet Infect Dis. 2008; 8(12): 796-803
  • 16. Chuang SK, Lau YL, Lim WL, Chow CB, Tsang T, Tse LY. Mass measles immunization campaign: experience in the Hong Kong Special Administrative Region of China. Bull World Health Organ. 2002; 80(7): 585-91[PubMed]
  • 17. Esteghamati A, Gouya MM, Zahraei SM, Dadras MN, Rashidi A, Mahoney F. Progress in measles and rubella elimination in Iran. Pediatr Infect Dis J. 2007; 26(12): 1137-41[DOI][PubMed]
  • 18. Salimi V, Mokhtri-azad T, Gooya MM, Hamkar R, Esteghamati AR, Varshochiyani SA, et al. Seroepidemiology of measles in 5-25-year-old age group before measles/rubella mass vaccination campaign in Tabriz (2003). Med J Tabriz Univ. 2006; 28(2): 77-82
  • 19. Jonaidi Jafari N, Ranjbar R, Kakaei M, Ghorbani GhA, Izadi M, Khosravi A, et al. [The Evaluation of Anti Measles IgG Antibody Level Five Years After Mass Vaccination of Measles- Rubella Among The Medical Students of Baqiyatallah University of Medical Sciences]. Sci J Ilam U Med Sci. 2010; 18(1): 34-9
  • 20. Pourabbas B, Ziyaeyan M, Alborzi A, Mardaneh J. Efficacy of measles and rubella vaccination one year after the nationwide campaign in Shiraz, Iran. Int J Infect Dis. 2008; 12(1): 43-6[DOI][PubMed]
  • 21. Savad Koohi R, Hajian K, Noori NA, Attarieh M. [Measurement of Measles antibody in 157 children aged 4-6 years referred to Amirkola Children Hospital, 2003-2004]. J Babol Univ Med Sci. 2006; 8(3): 55-9
  • 22. Shamsizadeh A, Nikfar R, Makvandi M, Hakimzadeh M, Alisamir M, Ziaei T. Seroprevalence of measles, mumps and rubella Antibodies in 18 months and 6.5 years old children: 6 months after measles-mumps-rubella (MMR) vaccination. Jundishapur J Microbiol. 2012; 5(4): 578-81[DOI]
  • 23. Yekta Z, Porali R, Taravati MR, Salary Sh, Khalily F, Shahabi S. Measles IgG sero-prevalence and its attributable factors in 5–25-year-old cases prior mass vaccination campaign in Urmia, northeastern Iran. Iran Red Crescent Med J. 2007; 9(1): 28-35
  • 24. Gozalan A, Korukluoglu G, Kurtoglu D, Miyamura K, Yilmaz N, Morita M, et al. Measles seroepidemiology in 3 cities in Turkey. Saudi Med J. 2005; 26(12): 1971-7[PubMed]
  • 25. Glass K, Grenfell BT. Waning immunity and subclinical measles infections in England. Vaccine. 2004; 22(29-30): 4110-6[DOI][PubMed]
  • 26. Gidding HF, Gilbert GL. Measles immunity in young Australian adults. Commun Dis Intell Q Rep. 2001; 25(3): 133-6[PubMed]
  • 27. Emami Naeini A, Ghazavi N, Emami Naeini S. Measurement of serum antibody Titer against Measles in a group of adults receiving Measles-Rubella mass vaccination. J Isfahan Med Sch. 2011; 28(114): 854-8
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments